Albert David Share Price

Albert David Share Price

NSE: ALBERTDAVD
|
Pharmaceuticals
|
S Cap
₹ 860.25
-₹9.90 (-1.14%)
1D
Last updated 04 Sep, 2026, 15:51 IST

Albert David Share Price Today

As of 5 Sep 2026, Albert David share price is ₹860.25. The stock opened at ₹876.90, compared to its previous close of ₹870.15. During today's trading session, Albert David share price moved in the range of ₹851.60 to ₹878.00, with an average price of ₹864.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹579.90 and a high of ₹931.85.

₹851.60
1.14% down today
₹878.00
1D LOW
1D HIGH

Albert David Returns Calculator

Circuit
L
H
₹688.20
₹1,032.30
52-week
L
H
₹579.90
₹931.85

About Albert David

Albert David Share Price
ISIN
INE155C01010
Sector Market Cap
₹ 490.12 Cr

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Albert David Financial Highlights

  • Revenue: Albert David reported revenue of ₹341.05 crore in FY26 vs ₹375.35 crore in FY25. It showed a decrease of 9.14% on a yearly basis.
  • Operating Profit: Albert David reported an operating profit of ₹0.52 crore in FY26 vs ₹25.23 crore in FY25. It showed a decrease of 97.94% on a year-on-year basis.
  • Net Profit: Albert David reported a net loss of ₹1.49 crore in FY26 vs ₹17.20 crore in FY25. It showed a decrease of 108.66% on a yearly basis.

Albert David Quarterly Result Highlights

  • Albert David reported revenue of ₹129.30 crore in Jun 2026, compared with ₹61.02 crore in Mar 2026, representing an increase of 111.90% on a quarter-on-quarter (QoQ) basis.
  • Albert David reported an operating profit of ₹35.79 crore in Jun 2026, compared with ₹25.23 crore in Mar 2026, representing an increase of 241.85% on a quarter-on-quarter (QoQ) basis.
  • Albert David reported a profit of ₹32.00 crore in Jun 2026, compared with ₹21.43 crore in Mar 2026, reflecting an increase of 249.32% on a QoQ basis.
  • The earnings per share (EPS) of Albert David stood at ₹2.62 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
62.24%
FII
0.57%
Other DII
1.62%
Retail and other
35.56%
Mutual funds
0.01%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.60%
Dec 20250.60%
Mar 20260.58%
Jun 20260.57%
Mkt Cap Cr
490.12
P/E
21.72
P/B
1.25
ROE
-0.38%
D/E
0.08
ROCE
0.75%
Div. Yield
0.58%
EPS(TTM)
-2.62
Turnover
0.70
EV/EBITDA
12.30
Net Margin
-0.45%
Op. Margin
3.95%
ROA
4.35%
Quick Ratio
2.74
Curr. Ratio
4.34
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Albert David outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Albert David appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,56,833.0037.605.4513.74%0.6117.33%93.240.84%0.4810.90
Divis Laboratories2,45,426.0082.5914.4115.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,87,320.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,13,217.0024.354.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,12,212.0033.343.2511.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs99,417.5091.1818.7616.77%0.4016.14%97.200.11%0.6713.72
Lupin97,626.3017.394.3023.76%0.0424.88%659.000.85%0.57129.18
Mankind Pharma96,179.6046.525.9011.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories96,405.5030.262.5311.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma93,614.0025.642.519.25%0.1911.76%394.820.24%0.3841.58

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Albert David Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹333.60₹345.77₹362.46₹341.56
Other Income₹7.45₹29.58₹57.55₹15.40
Total Revenue₹341.05₹375.35₹420.01₹356.96
Total Expenses₹340.53₹350.12₹322.73₹306.23
Profit Before Tax₹0.52₹25.23₹97.29₹50.74
Tax₹2.02₹8.03₹21.87₹14.56
Profit After Tax-₹1.49₹17.20₹75.42₹36.17
EPS - Basic-₹2.62₹30.14₹132.15₹63.39
EPS - Diluted-₹2.62₹30.14₹132.15₹63.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.52₹25.23₹97.29₹50.74
Income before WC changes₹12.40₹9.44₹52.84₹52.06
Change in Assets-₹5.79-₹20.43₹7.50-₹16.74
Change in Liabilities-₹9.28-₹8.94₹1.27-₹9.09
Change in WC-₹15.07-₹29.37₹8.77-₹25.84
Cash flow from Operations-₹7.66-₹28.44₹45.50₹10.52
Cash flow from Investing-₹4.40₹23.30-₹33.25-₹5.00
Cash flow from Financing₹11.92₹0.11-₹8.27-₹6.36
Total Cash Flow-₹0.14-₹5.02₹3.98-₹0.84
Cash (Start of the year)₹0.42₹5.44₹1.45₹2.28
Cash (End of the year)₹0.30₹0.42₹5.44₹1.45

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹144.73₹157.37₹126.36₹119.16
Current Assets₹374.40₹354.05₹371.63₹304.24
Total Assets₹519.13₹511.42₹497.99₹423.39
Current Liabilities₹115.43₹104.18₹99.05₹98.94
Net Current Asset₹258.97₹249.87₹272.59₹205.30
Non-Current Liabilities₹12.17₹14.75₹15.96₹12.88
Equity Capital₹391.54₹392.48₹382.98₹311.57
Total Equity & Liabilities₹519.13₹511.42₹497.99₹423.39
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
4
Bullish
3
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
61.03
Neutral
ATR (14)
30.23
Neutral
STOCH(9,6)
10.78
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
67.9
Bearish
UO(9)
45.52
Neutral
ROC(12)
2.47
Bullish
WillR(14)
-50.91
Neutral
Period
Simple value
Exponential vaue
5D
874.34
870.57
10D
878.69
867.49
20D
848.88
842.71
50D
761.19
788.9
100D
741.93
756.22
Volume trend — traded volume by day
4 Sep0L
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Albert David Share Price
Albert David
Pharmaceuticals
Add Stock
Add Another

Albert David Share Price FAQs

Albert David share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837